108th CONGRESS
1st Session
S. 542
To amend title XIX of the Social Security Act to clarify that section
1927 of that Act does not prohibit a State from entering into drug rebate agreements
in order to make outpatient prescription drugs accessible and affordable for
residents of the State who are not otherwise eligible for medical assistance
under the medicaid program.
IN THE SENATE OF THE UNITED STATES
March 5, 2003
Ms. Stabenow (for herself, Mrs. Boxer, Mr. Dorgan, Mr. Leahy, Mr. Levin, Mr.
Schumer, and Mr. Johnson) introduced the following bill; which was read twice
and referred to the Committee on Finance
A BILL
To amend title XIX of the Social Security Act to clarify that section
1927 of that Act does not prohibit a State from entering into drug rebate agreements
in order to make outpatient prescription drugs accessible and affordable for
residents of the State who are not otherwise eligible for medical assistance
under the medicaid program.
Be it enacted by the Senate and House of Representatives of the United States
of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the `Rx Flexibility for States Act'.
SEC. 2. CLARIFICATION OF STATE AUTHORITY RELATING TO MEDICAID DRUG REBATE
AGREEMENTS.
Section 1927 of the Social Security Act (42 U.S.C. 1396r-8) is amended by adding
at the end the following:
`(l) RULE OF CONSTRUCTION- Nothing in this section shall be construed as prohibiting
a State from--
`(1) directly entering into rebate agreements (on the State's own initiative
or under a section 1115 waiver approved by the Secretary before, on, or after
the date of enactment of this subsection) that are similar to a rebate agreement
described in subsection (b) with a manufacturer for purposes of ensuring the
affordability of outpatient prescription drugs in order to provide access
to such drugs by residents of a State who are not otherwise eligible for medical
assistance under this title; or
`(2) making prior authorization (that satisfies the requirements of subsection
(d) and that does not violate any requirements of this title that are designed
to ensure access to medically necessary prescribed drugs for individuals enrolled
in the State program under this title) a condition of not participating in
such a similar rebate agreement.'.
END